Φορτώνει......
Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence
Heart failure (HF) is a growing health concern in aging societies worldwide. Sacubitril/valsartan is changing the real-world treatment in the whole spectrum of HF. The beginning was the PARADIGM-HF trial published in 2014, which demonstrated the beneficial effects of inhibiting natriuretic peptide b...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Korean J Intern Med |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The Korean Association of Internal Medicine
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214374/ https://ncbi.nlm.nih.gov/pubmed/32392658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2020.105 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|